MENU
NBY
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
NovaBay Pharmaceuticals (NBY) Ownership - Who owns NovaBay Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.59M
P/E Ratio
N/A
Total Cash
776K
Projected Growth
N/A
Total Debt
1.26M
Revenue
13.84M
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash/Share
0.16
Total Debt/Equity
N/A
Revenue/Share
9.57 USD as % of share price
Fundamentals
NBY
Capitalization
2.59M
P/E Ratio
N/A
Risk (Beta)
0.47
Dividend Yield
N/A
Total Cash
776K
Total Cash/Share
0.16
Total Debt
1.26M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
9.57%
Revenue
13.8M
ROE
N/A
Book Value
1.07M
P/B Ratio
2.43
Cash Flow
N/A
Earnings
-62.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
49K
Current Ratio
1.15
Current Revenue Per Employee
93884.62
Dividends Per Share - Security
N/A
EBITDA
-6.52M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.26
Revenue To Assets
-198.04
Shares Held By Institutions
98.3K
Shares Outstanding - Current
4.89M
Total Liabilities
2.81M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-92.578
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com